MedPath

湖北美思创药业有限公司

Ownership
-
Established
2016-10-08
Employees
-
Market Cap
-
Website
www.meisichuang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

Compound Paracetamot and Amantadine Lydrochioidecapsules

Product Name
复方氨酚烷胺胶囊
Approval Number
国药准字H52020689
Approval Date
Oct 17, 2024
NMPA

复方半夏止咳糖浆

Approval Number
国药准字Z20027688
Approval Date
Jan 10, 2022
NMPA

藿香正气合剂

Approval Number
国药准字Z33021019
Approval Date
Jan 10, 2022
NMPA

小儿感冒颗粒

Approval Number
国药准字Z36020327
Approval Date
Sep 17, 2021
NMPA

小儿止咳糖浆

Approval Number
国药准字Z61021179
Approval Date
Dec 16, 2020
NMPA

Paracetamol,Caffeine,Artificial Cow-bezoar and Chlorphenamine Maleate Capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H42022555
Approval Date
Sep 8, 2020
NMPA

Ketoprofen Tablets

Product Name
酮洛芬片
Approval Number
国药准字H20055826
Approval Date
Sep 8, 2020
NMPA

金银花露

Approval Number
国药准字Z45020217
Approval Date
Aug 20, 2020
NMPA

小儿咳喘灵颗粒

Approval Number
国药准字Z20044431
Approval Date
Aug 8, 2020
NMPA

炎热清片

Approval Number
国药准字Z20050502
Approval Date
Aug 7, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.